Welcome! This is the NEW free version of the SciBITES Pharma News Engine from SciBite. By using this site you to accept our Terms & Conditions which the use of cookies to enhance your user experience.


Here is the latest news for your query in chronological order, most recent articles at the top. Use the options on the right to filter and customise this news feed.

  Todays Live Pharma News Articles ...

PETMED SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against PetMed Express, Inc. - (PETS)
http://www.prnewswire.com, , 23-Sep-2017
TEVA PHARMACEUTICAL SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Teva Pharmaceutical Industries Limited - (TEVA)
http://www.prnewswire.com, , 23-Sep-2017
Quest Diagnostics Responds to Proposed PAMA 2018 Medicare Payment Rates for Clinical Laboratory Tests
http://www.prnewswire.com, , 23-Sep-2017
FDA Approves Merck's Keytruda, Agilent Dako CDx for Gastric Cancer Indications
http://feeds.genomeweb.com, , 23-Sep-2017
FDA Approves Merck's Keytruda, Agilent Dako CDx for Gastric Cancer Indications
Allergan Receives Refusal to File Letter from FDA for Vraylar® (cariprazine) Supplemental New Drug Application (sNDA) for the Treatment of Negative Symptoms in Schizophrenia
http://www.prnewswire.com, , 22-Sep-2017
Janssen Receives Complete Response Letter From U.S. FDA For Sirukumab Biologics License Application
http://www.prnewswire.com, , 22-Sep-2017
AbbVie, Bristol-Myers Squibb to evaluate solid tumors therapeutic regimen
http://www.centerwatch.com, , 22-Sep-2017
Your Daily Pharma Scoop: VanEck Vectors Biotech ETF, Esperion's Growth Potential, Pfizer's EU Approval
https://seekingalpha.com, , 22-Sep-2017
FiercePharmaAsia—Big Pharma’s performance, Fosun’s revised Gland buy, Arcus-Taiho cancer deal
http://www.fiercepharma.com, , 22-Sep-2017
New Data from CENTAUR Phase 2b Clinical Study Supports Continued Development of Cenicriviroc (CVC) in Ongoing Phase 3 AURORA Trial
http://www.prnewswire.com, , 22-Sep-2017
AbbVie and Bristol-Myers Squibb announce clinical research collaboration to evaluate a therapeutic regimen in advanced solid tumors
http://www.worldpharmanews.com, , 22-Sep-2017
Novartis and The Max Foundation transform pioneering cancer access program for people in lower-income countries
http://www.worldpharmanews.com, , 22-Sep-2017
Buffered versus non-buffered fluids given to adults during surgery
http://feedproxy.google.com, , 22-Sep-2017
New Data from CENTAUR Phase 2b Clinical Study Supports Continued Development of Cenicriviroc (CVC) in Ongoing Phase 3 AURORA Trial
AbbVie and Bristol-Myers Squibb Announce Clinical Research Collaboration to Evaluate a Therapeutic Regimen in Advanced Solid Tumors
Abbott Secures FDA Approval for MRI-Compatibility for the Company's Ellipse™ ICD
http://www.prnewswire.com, , 22-Sep-2017
Merck, Pfizer get EC approval for skin cancer drug Bavencio
http://regulatoryaffairs.pharmaceutical-business-review.com, , 22-Sep-2017
AbbVie and Bristol-Myers Squibb Announce Clinical Research Collaboration to Evaluate a ...
http://www.biomedreports.com, , 22-Sep-2017
Eleven Biotherapeutics Announces Completion of Vicinium Manufacturing for Ongoing Clinical ...
http://www.biomedreports.com, , 22-Sep-2017
Showing Records 0 ... 20  


SciBite
The Language Of Science

SciBite provides text-analytics and data intelligence software for drug discovery, clinical and competitor intelligence and much more for pharma, healthcare and life sciences.

This is a Limited, Free Service only touching the surface of how SciBite's tools transform biomedical text, literature, patents, internal documents and news into a rich intelligence network. If you'd like to know more, contact us to see how our tools can transform your work today!

Topic Activity & Tools

Get Daily Alerts!

Click For Email & RSS Alerts

About/Links

Query: Live Pharma News
Type: Query